PF-08634404
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for PF-08634404, covering 2026-03-23 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer [Phase 3]